(Q33771816)

29 July 2017

Antisense oligonucleotides: a systematic high-throughput approach to target validation and gene function determination (English)

1 reference

29 July 2017

Taylor MF

1

1 reference

PubMed ID

10557138

29 July 2017

Wiederholt K

series ordinal

2

1 reference

PubMed ID

10557138

29 July 2017

Sverdrup F

series ordinal

3

1 reference

29 July 2017

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

4

1 reference

29 July 2017

12

1 reference

29 July 2017

562-567

1 reference

The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Specificity of antisense oligonucleotides in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Does antisense exist?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Antisense comes of age

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

An overview of progress in antisense therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

First "antisense" drug will treat CMV retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Shutting down a gene. Antisense drug wins approval

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Antisense oligonucleotides: is the glass half full or half empty?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Mixed backbone oligonucleotides: improvement in oligonucleotide-induced toxicity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modifications

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Correlating structure and stability of DNA duplexes with incorporated 2'-O-modified RNA analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Molecular mechanisms of antisense drugs: RNase H.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Translation inhibition by an mRNA coding region secondary structure is determined by its proximity to the AUG initiation codon

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Elucidation of gene function using C-5 propyne antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Potent and selective gene inhibition using antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

A cytosine analog that confers enhanced potency to antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Biophysical and antisense properties of oligodeoxynucleotides containing 7-propynyl-, 7-iodo- and 7-cyano-7-deaza-2-amino-2'-deoxyadenosines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

A role for c-Raf kinase and Ha-Ras in cytokine-mediated induction of cell adhesion molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Functional genomics: going forwards from the databases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Tapping the potential of molecular libraries in functional genomics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Potent and selective inhibition of gene expression by an antisense heptanucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

The polymerase chain reaction: from functional genomics to high-school practical classes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Rostrum of a toothed whale: ultrastructural study of a very dense bone

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Microarrays: biotechnology's discovery platform for functional genomics.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Systematic functional analysis of the yeast genome

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

Drug target validation and identification of secondary drug target effects using DNA microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

New goals for the U.S. Human Genome Project: 1998-2003.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

A good antisense molecule is hard to find

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901392-6

7 January 2021

10.1016/S1359-6446(99)01392-6

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10557138